Rich Legacy of Innovation & Care
Rich Legacy of Innovation & Care
Founder
Our company is distinguished by the superior quality and innovation of our products, the reliability and integrity of our commercial transactions, and our unwavering commitment to exceptional customer service. Our objective is to consistently lead our field and maintain our esteemed credibility at every level.
Komninos Gamvroulis
Growth Journey
1978
Verma Drugs established by Komninos Gamvroulis, beginning acetic acid dialysis solution production.
1986
Started production of sodium bicarbonate (NaHCO3) dialysis solutions.
1987
Launched Vermalton and peritoneal dialysis (PD) solutions.
1989
Expanded into amino acid production.
1990
Introduced acidic dialysis solutions.
1992
Formed a strategic partnership with Terumo.
1998
Achieved GMP and ISO compliance.
1999
Established a state-of-the-art 7,000 m² production facility.
2000
Launched the Verma Cart.
2000
Partnered with Medionics.
2001
Introduced Vermafil and collaborated with Asahi Rexeed Dialyzers.
2002
Launched the Verma-Ci-Cart.
2005
Introduced Vermasol and Set PD products.
2006
Launched the VermaBag.
2007
Expanded into international markets and strengthened R&D capabilities.
2007
Collaborated with Hbiofluids for Vermathen
2008
Partnered with Hbiofluids for the Vermalin  and Vermalton brand.
2012
Launched the Verma-Ci-Bag.
2016
Introduced the VermaClean Series.
2017
Launched VermaCitra, CitraVit, and Verma-C Solutions.
2018
Partnered with Ecotrade in Serbia.
2019
Expanded B2B activities with Ariti and Alkaloid; made strategic investments in Newsol and Dialife.
2020
Established the Polyxenia Renal Clinic.
2021
Launched the PD VermaCap.
2022
Began manufacturing DEMO dialysis solutions.
2023
Enhanced export activities through partnerships with KK Farma and Iperboreal.